Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification

Cited by (239)

Items 101–200 of 239

1. Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
   Yihong Deng, Eric C. Polley, Joshua David Wallach, Sanket Shishir Dhruva, Jeph S. Herrin, Kenneth Quinto, Charu Gandotra, William H. Crown, Peter A. Noseworthy, Xiaoxi Yao et al. · 2022 · BMJ
2. Blood Pressure Management in Patients With Diabetes
   Amanda H. Salanitro, Christianne L. Roumie · 2010 · Clinical Diabetes
3. Adherence to laboratory test requests by patients with diabetes: the Diabetes Study of Northern California (DISTANCE).
   Howard H. Moffet, Melissa M. Parker, Urmimala Sarkar, Dean Schillinger, Alicia Fernández, Nancy E. Adler, Alyce Sophia Adams, Andrew John Karter · 2011 · PubMed
4. The achievement of glycaemic, blood pressure and LDL cholesterol targets in patients with type 2 diabetes attending a South African tertiary hospital outpatient clinic
   Yacob Pinchevsky, Vaibhav Shukla, Neil Butkow, Frederick Johan Raal, Tobias Freeman Chirwa · 2015 · Journal of Endocrinology Metabolism and Diabetes of South Africa
5. Initial Antihyperglycemic Drug Therapy Among 241 327 Adults With Newly Identified Diabetes From 2005 Through 2010
   Marsha A. Raebel, Stanley Xu, Glenn K. Goodrich, Emily B. Schroeder, Julie A. Schmittdiel, Jodi B Segal, Patrick J. O’Connor, Gregory A. Nichols, Jean M. Lawrence, Henry Lester Kirchner et al. · 2013 · Annals of Pharmacotherapy
6. Patient-Centered Outcomes of a Value-Based Insurance Design Program for Patients with Diabetes
   Daniel J. Elliott, Edmondo J. Robinson, Karen B. Anthony, Paula L. Stillman · 2013 · Population Health Management
7. An exploration of attitudes toward the use of patient incentives to support diabetes self-management
   Katherine Blondon, Predrag Klasnja, Katie Coleman, Wanda Pratt · 2013 · Psychology and Health
8. Medicare Star excludes diabetes patients with poor CVD risk factor control.
   Julie A. Schmittdiel, Marsha A. Raebel, Wendy Dyer, John F. Steiner, Glenn K. Goodrich, Andy J. Karter, Gregory A. Nichols · 2014 · PubMed
9. The power of two: an update on fixed-dose combinations for type 2 diabetes
   Stewart B. Harris · 2016 · Expert Review of Clinical Pharmacology
10. Predictors of Medication‐Related Problems among Medicaid Patients Participating in a Pharmacist‐Provided Telephonic Medication Therapy Management Program
    Margie E. Snyder, Caitlin K. Frail, Heather A. Jaynes, Karen Steinmetz Pater, Alan J. Zillich · 2014 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
11. Using Simulation Technology to Teach Diabetes Care Management Skills to Resident Physicians
    JoAnn M. Sperl‐Hillen, Patrick J. O’Connor, Heidi L. Ekstrom, William Rush, Stephen E. Asche, Omar D. Fernandes, Deepika Appana, Gerald H. Amundson, Paul Johnson · 2013 · Journal of Diabetes Science and Technology
12. Missed Opportunities for Treatment of Uncontrolled Hypertension at Physician Office Visits in the United States, 2005 Through 2009
    Raman Ravi Khanna, Ronald G. Victor, Kirsten B. Bibbins-Domingo, Martin F. Shapiro, Mark J. Pletcher · 2012 · Archives of Internal Medicine
13. Racial disparities in lipid control in patients with diabetes.
    Darcy Saffar, Keoki L Williams, Jennifer Elston Lafata, George Divine, Manel Pladevall · 2012 · PubMed
14. A pilot quality improvement intervention in patients with diabetes and hypertension in primary care settings of Cyprus
    George Samoutis, Elpidoforos Soterakis Soteriades, Jelle Stoffers, Anastas E. Philalithis, Evi Delicha, Christos D Lionis · 2010 · Family Practice
15. Therapeutic inertia and contributing factors among ambulatory patients with hypertension
    Yirga Legesse Niriayo, Solomon Girmay, Nigusse Tesfay, Kidu Gidey, Solomon Weldegebreal Asgedom · 2024 · BMC Cardiovascular Disorders
16. Sodium Glucose Cotransporter 2 and Dipeptidyl Peptidase-4 Inhibition: Promise of a Dynamic Duo
    Ildiko Lingvay · 2017 · Endocrine Practice
17. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme
    Richard F. Hobbs, Gianfranco Gensini, G.B. John Mancini, Athanasios John Manolis, Beverly Bauer, Jacques J. Genest, Ross D. Feldman, Peter Harvey, Trond Geir Jenssen, Pedro Marques da Silva et al. · 2009 · European Journal of Cardiovascular Prevention & Rehabilitation
18. Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study
    Machaon Bonafede, Arthi Chandran, Stefan DiMario, Rita Saltiel-Berzin, Drilon Saliu · 2016 · BMJ Open Diabetes Research & Care
19. Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE−2 study
    Cesare Berra, Roberto Manfrini, Francesco Bifari, Elisa Cipponeri, Renata Ghelardi, Lucia Centofanti, Umberto Mortola, Elena Lunati, Loredana G Bucciarelli, Vincenzo Cimino et al. · 2024 · Pharmacological Research
20. The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes
    Caroline Holm Nørgaard, Mitra Mosslemi, Christina Ji‐Young Lee, Christian Tobias Torp-Pedersen, Nathan D. Wong · 2019 · Current Cardiology Reports
21. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes
    Jennifer Elston Lafata, Andrew John Karter, Patrick J. O’Connor, Heather Morris, Julie A. Schmittdiel, Scott M. Ratliff, Katherine M. Newton, Marsha A. Raebel, Ram D. Pathak, Abraham Thomas et al. · 2015 · Journal of General Internal Medicine
22. Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study
    S. Halimi, Beverley Balkau, Claude Attali, B. Detournay, Elisabeth Amelineau, Jean‐Frédéric Blickle · 2012 · Diabetes & Metabolism
23. Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes
    Robert J. Romanelli, Sukyung Chung, Jia Pu, Vani C Nimbal, Beinan Zhao, Latha P Palaniappan · 2015 · Diabetes Research and Clinical Practice
24. Pharmacists on primary care teams: Effect on antihypertensive medication management in patients with type 2 diabetes
    Dima Omran, Sumit R. Majumdar, Jeffrey A. Johnson, Ross T. Tsuyuki, Richard Z Lewanczuk, Lisa M. Guirguis, Mark J. Makowsky, Scot H. Simpson · 2015 · Journal of the American Pharmacists Association
25. Outpatient EHR-Based Diabetes Clinical Decision Support That Works: Lessons Learned From Implementing Diabetes Wizard
    JoAnn M. Sperl‐Hillen, Beth M. Averbeck, Kevin J. Palattao, Jerry H. Amundson, Heidi L. Ekstrom, Bill Rush, Patrick J. O’Connor · 2010 · Diabetes Spectrum
26. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes
    Marsha A. Raebel, Wendy Dyer, Gregory A. Nichols, Glenn K. Goodrich, Julie A. Schmittdiel · 2017 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
27. Comorbidities in Recent-Onset Adult Type 1 Diabetes: A Comparison of German Cohorts
    Oana‐Patricia Zaharia, Stefanie Lanzinger, Joachim Rosenbauer, Wölfram Karges, Karsten Müssig, Sebastian M. Meyhöfer, Volker Burkart, Michael Hummel, Dirk Raddatz, Michael Roden et al. · 2022 · Frontiers in Endocrinology
28. Designing a Natural Experiment to Evaluate a National Health Care–Community Partnership to Prevent Type 2 Diabetes
    Ronald T. Ackermann, Ann M. Holmes, Chandan Saha · 2013 · Preventing Chronic Disease
29. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial
    Xiulin Shi, Jiang He, Mingzhu Lin, Changqin Liu, Bing Yan, Haiqu Song, Caihong Wang, Fangsen Xiao, Peiying Huang, Liying Wang et al. · 2021 · American Heart Journal
30. Initiation of treatment for incident diabetes: Evidence from the electronic health records in an ambulatory care setting
    Sukyung Chung, Beinan Zhao, Diane S. Lauderdale, Randolph B. Linde, Randall Scott Stafford, Latha P Palaniappan · 2014 · Primary care diabetes
31. Patient-Reported Racial/Ethnic Healthcare Provider Discrimination and Medication Intensification in the Diabetes Study of Northern California (DISTANCE)
    Courtney Rees Lyles, Andrew John Karter, Bessie Ann Young, Clarence Spigner, David E. Grembowski, Dean Schillinger, Nancy Adler · 2011 · Journal of General Internal Medicine
32. Addressing Hypertension Outcomes Using Telehealth and Population Health Managers: Adaptations and Implementation Considerations
    Connor Drake, Allison A. Lewinski, Abigail Rader, Julie K. Schexnayder, Hayden Barry Bosworth, Karen M. Goldstein, Jennifer M. Gierisch, Courtney White‐Clark, Felicia McCant, Leah L. Zullig · 2022 · Current Hypertension Reports
33. A Comparison Between Antihypertensive Medication Adherence and Treatment Intensification as Potential Clinical Performance Measures
    Rebecca Vigen, Susan M. Shetterly, David J. Magid, Patrick J. O’Connor, Karen L. Margolis, Julie A. Schmittdiel, P. Michael Ho · 2012 · Circulation Cardiovascular Quality and Outcomes
34. International challenges without borders: a descriptive study of family physicians' educational needs in the field of diabetes
    Suzanne Murray, Patrice Lazure, Sara Schroter, Philipp J. Leuschner, Peter Posel, Thomas Kellner, Richard D Jenkins · 2011 · BMC Family Practice
35. Non-Adherence To Treatment Among Diabetic Patients Attending Outpatients Clinic At Mutare Provincial Hospital, Manicaland Province, Zimbabwe.
    Winnie Mandewo, Edward Edward, Esperanza Dodge, Auxilia Chideme-Munodawafa, George Mandewo · 2014 · International journal of scientific and technology research
36. Consumers' characteristics associated with the use of mail pharmacy services in the United States: Findings from the 2015 National Consumer Survey on the Medication Experience
    Mohamed Rashrash, Daniel M. Tomaszewski, Jon C. Schommer, Lawrence M. Brown · 2016 · Journal of the American Pharmacists Association
37. Influence of Patient Coaching on Analgesic Treatment Adjustment: Secondary Analysis of a Randomized Controlled Trial
    Richard L. Kravitz, Daniel Joseph Tancredi, Anthony F. Jerant, Naomi H. Saito, Richard Lewis Street, Tim Grennan, Peter John Franks · 2012 · Journal of Pain and Symptom Management
38. Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study
    Romera, Irene, Díaz, Silvia, Sicras-Mainar, Antoni, López-Simarro, Flora, Dilla, Tatiana, Artime, Esther, Reviriego, Jesús · 2020 · Diabetes Therapy
39. Cost Implications to Health Care Payers of Improving Glucose Management among Adults with Type 2 Diabetes
    Teryl K. Nuckols, Elizabeth A. McGlynn, John Adams, Julie Lai, Myong-Hyun Go, JOAN W. KEESEY, Julia E. Aledort · 2011 · Health Services Research
40. Effects of patient volume on quality of outpatient diabetes care
    Jun‐Sing Wang, Shih‐Yi Lin, Wayne Huey‐Herng Sheu, I‐Te Lee, Li‐Nien Tseng, Yu-Ming Song · 2009 · Diabetes Research and Clinical Practice
41. The Association of Patient Age with Cardiovascular Disease Risk Factor Treatment and Control in Diabetes
    Usha Subramanian, Julie A. Schmittdiel, Neha Gavin, Ana H. Traylor, Connie S. Uratsu, Joe V. Selby, Carol M. Mangione · 2009 · Journal of General Internal Medicine
42. Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive study
    Folgerdiena M. de Vries, Jaco Voorham, Eelko Hak, Petra Denig · 2016 · International Journal of Clinical Practice
43. Associations between immigrant status and pharmacological treatments for diabetes in U.S. adults.
    Loretta Hsueh, Elizabeth A. Vrany, Jay S. Patel, Nicole A. Hollingshead, Adam Todd Hirsh, Mary de Groot, Jesse C. Stewart · 2017 · Health Psychology
44. Predictors of Self-Efficacy in Administering Insulin Injection
    Mei‐Chuan Huang, Chich‐Hsiu Hung, Ya-Wen Huang, Su-Ching Yang · 2019 · Clinical Nursing Research
45. The Impact of a Decision Support Tool Linked to an Electronic Medical Record on Glycemic Control in People with Type 2 Diabetes
    Waruna Gunathilake, Sajith Gunawardena, Ranga Fernando, George Thomson, Devaka J.S. Fernando · 2013 · Journal of Diabetes Science and Technology
46. Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study
    Vasilios Gabriel Athyros, Apostolos Ioannis Hatzitolios, Asterios I. Karagiannis, Triantafyllos Didangelos, Fotios S Iliadis, S. Dolgyras, Th. Vosnakidis, P. Vasiliadis, I. Malias, Κωνσταντίνος Τζιόμαλος et al. · 2009 · Current Medical Research and Opinion
47. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States
    Gail F. Fernandes, Baanie Sawhney, Hakima Hannachi, Jinan Liu, Tongtong Wang, Alex Z. Fu, Kristy Iglay, Annie McNeill, Swapnil N. Rajpathak · 2020 · Current Medical Research and Opinion
48. Therapeutic Gaming for Adolescent Anxiety
    Steven Barnes, Julie Prescott · 2021 · Advances in psychology, mental health, and behavioral studies (APMHBS) book series
49. Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP ‐1 analogue versus progression to basal‐bolus therapy
    Irl B. Hirsch, John B. Buse, J.L. Leahy, Janet B. McGill, Anne L. Peters, Helena W. Rodbard, R. R. Rubin, Jay S. Skyler, Carol A. Verderese, Matthew C. Riddle · 2013 · Diabetes Obesity and Metabolism
50. Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial
    Joe V. Selby, Julie A. Schmittdiel, BRUCE H. FIREMAN, Marc G. Jaffe, Laura J. Ransom, Wendy Dyer, Connie S. Uratsu, Mary Reed, Eve A. Kerr, John Hsu · 2012 · BMC Health Services Research
51. A Qualitative Assessment of Educational Opportunities for Primary Care Providers in Type 2 Diabetes Care
    Kayla N. Cytryn, William Timothy Garvey, Sean M. Hayes, Linda Cann, Suzanne Murray · 2009 · Diabetes Spectrum
52. Evaluating the Emergency Department Observation Unit for the management of hyperglycemia in adults
    Colin J. Crilly, Amy Allen, Teresa M. Amato, Allison Tiberio, Rifka C. Schulman, Robert A. Silverman · 2018 · The American Journal of Emergency Medicine
53. Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010.
    Rozalina G. McCoy, Yuanhui Zhang, Jeph S. Herrin, Brian T. Denton, Jennifer E. Mason, Víctor M. Montori, Steven A. Smith, Nilay D. Shah · 2015 · PubMed
54. Viewpoint: Using the patient-centred medicine clinical framework to better appreciate and explore the many barriers to care in Type 2 diabetes
    Ron Janes, Janet Titchener · 2014 · Journal of Primary Health Care
55. Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story
    Israel Hodish · 2018 · Clinical Diabetes and Endocrinology
56. A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy
    Susan Guzman · 2020 · Diabetes Spectrum
57. Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial
    Yihong Deng, Eric C. Polley, Joshua David Wallach, Jeph S. Herrin, Joseph S. Ross, Rozalina G. McCoy · 2023 · BMJ Medicine
58. Socioeconomic and modifiable predictors of blood pressure control for hypertension in primary care attenders in the Western Cape, South Africa
    Naomi Folb, Max Oscar Bachmann, E D Bateman, Krisela Steyn, Naomi Sharlene Levitt, Venessa Timmerman, Carl J. Lombard, Thomas Andrew Gaziano, Lara Rosemary Fairall · 2016 · South African Medical Journal
59. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes
    Tamer G. Yacoub · 2017 · Postgraduate Medicine
60. Impact of a quality improvement intervention on provider adherence to recommended standards of care for adults with type 2 diabetes mellitus
    Marie Umar-Kamara, Kimberly Adams Tufts · 2013 · Journal of the American Association of Nurse Practitioners
61. Psychosoziales und Diabetes
    Bernhard Kulzer, Christian Albus, Stefan Herpertz, Johannes Kruse, K. Lange, Florian Lederbogen, Frank Petrak · 2015 · Diabetologie und Stoffwechsel
62. Predictors of achieving HbA1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study
    Paul Elie Valensi, J. Shában, Marian Benroubi, Ryuzo Kawamori, Vito Borzı̀, Siddharth N Shah, Yang Wenying, Vinay Prusty, Jes Birger Hansen, Janusz Gumprecht et al. · 2013 · Current Medical Research and Opinion
63. Adherence by primary care physicians to guidelines for the clinical management of dyslipidemia.
    Geva Vashitz, Joachim Meyer, Yisrael Parmet, Yaakov Henkin, Roni Peleg, Nicky Liebermann, Harel Gilutz · 2011 · PubMed
64. Supporting Practices to Adopt Registry-Based Care (SPARC): protocol for a randomized controlled trial
    Rebecca Etz, Rosalind E. Keith, Anna M. Cody, Karen Stein, Roy Sabo, Melissa S. Hayes, Purvi Sevak, John Holland, Jesse C. Crosson · 2015 · Implementation Science
65. The Kidney as a Treatment Target for Type 2 Diabetes
    Betsy B. Dokken · 2012 · Diabetes Spectrum
66. Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study
    Neda Ratanawongsa, Andrew John Karter, Judy Quan, Melissa M. Parker, Margaret A. Handley, Urmimala Sarkar, Julie A. Schmittdiel, Dean Schillinger · 2015 · Journal of Managed Care & Specialty Pharmacy
67. Address Changes Are Associated With Unmet Glycemic Targets: Opportunities to Improve Processes and Outcomes of Care Among People With Type 2 Diabetes
    Tainayah Thomas, Wendy Dyer, Alyce Sophia Adams, Richard William Grant, Julie A. Schmittdiel · 2022 · The Permanente Journal
68. Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial
    Nancy Haff, Sushama Kattinakere Sreedhara, Wendy Wood, Elad Yom‐Tov, Daniel M. Horn, Melissa Hoover, Greg Low, Julie C. Lauffenburger, Alexander M. Chaitoff, Massimiliano Russo et al. · 2023 · American Heart Journal
69. Patient Complexity and Diabetes Quality of Care in Rural Settings
    Amanda H. Salanitro, Monika M. Safford, Thomas K. Houston, Jessica Hillman Williams, Fernando Ovalle, Pamela Payne‐Foster, Jeroan J. Allison, Carlos A. Estrada · 2011 · Journal of the National Medical Association
70. SGLT2 Inhibition: A Novel Prospective Strategy in Treatment of Diabetes Mellitus
    Aaishwarya B. Deshmukh, Maharshi C. Patel, Bharat Mishra · 2013 · Renal Failure
71. Impacto de la inercia terapéutica y del grado de adherencia al tratamiento en los objetivos de control en personas con diabetes
    Flora López‐Simarro, Irene Moral, Alba Aguado-Jodar, Cèlia Cols-Sagarra, José Mancera‐Romero, Margarita Alonso-Fernández, Sònia Miravet-Jiménez, Carlos Brotons · 2017 · Medicina de Familia SEMERGEN
72. Improving Adherence to Treatment Guidelines
    Esteban Gándara, Thomas T. Moniz, Mary Lou Dolan, Caroline Melia, Jessica C. Dudley, Allen John Smith, Allen B. Kachalia · 2009 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
73. A novel approach to optimise glycaemic control in insulin users
    Eran Bashan, Roy Harper, Yixi Bi, Israel Hodish · 2015 · BMJ Case Reports
74. The individual contribution and relative importance of self-management and quality of care on glycaemic control in type 2 diabetes
    Yolanda V. Martinez, Stephen Campbell, Mark Hann, Peter Bower · 2016 · Salud Pública de México
75. Patient Adherence: Challenges, Myths, and Realities
    Joel Rodríguez‐Saldaña · 2023 · Springer eBooks
76. Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected healthcare institutions in Colombia
    Nelson Alvis‐Guzmán, Martín Romero, Fernando Salcedo‐Mejía, María Carrasquilla-Sotomayor, Lina Gómez, Mónica María Rojas, Juan Camilo Urrego, Claudia Catalina Beltrán, Jaime Enrique Ruíz, Adriana Velásquez et al. · 2024 · Diabetology & Metabolic Syndrome
77. Language-concordant automated telephone queries to assess medication adherence in a diverse population: a cross-sectional analysis of convergent validity with pharmacy claims
    Neda Ratanawongsa, Judy Quan, Margaret A. Handley, Urmimala Sarkar, Dean Schillinger · 2018 · BMC Health Services Research
78. Patient Adherence: Challenges, Myths, and Realities
    Joel Rodríguez‐Saldaña · 2019 · Springer eBooks
79. Improving the Quality of Quality Measurement
    Monika M. Safford · 2009 · Medical Care
80. Statin use and low-density lipoprotein cholesterol target achievement for primary prevention of atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus: a multicenter cross-sectional study in Sri Lanka
    Warsha De Zoysa, Thilak Priyantha Weerarathna, Nuwan Darshana, Keddagoda Gamage Piyumi Wasana, B. Piyasekara, M. M. P. T. Jayasekara, Vathulan Sujanitha, Shehan Silva, Chamila D. Mettananda, G. U. Ramadasa et al. · 2025 · PLoS ONE
81. Understanding Uncontrolled Hypertension
    Dan R. Berlowitz · 2016 · Journal of Clinical Hypertension
82. Supporting general practitioner-based care for poorly controlled type 2 diabetes mellitus (the DECIDE study): feasibility study and protocol for a pilot cluster randomised controlled trial
    Mark E Murphy, Molly Byrne, Fiona Boland, Derek Corrigan, Paddy Gillespie, Tom P Fahey, Susan M. Smith · 2018 · Pilot and Feasibility Studies
83. For debate; pharmacological priorities in advanced type 2 diabetes
    Israel Hodish · 2019 · Journal of Diabetes and its Complications
84. Can the current healthcare delivery model cope with advanced type 2 diabetes?
    Israel Hodish · 2015 · Journal of Diabetes and its Complications
85. Das Diabetes-Ampelschema - Entwicklung eines Instruments für das hausärztliche Case Management bei Patienten mit Diabetes mellitus
    Corinne Chmiel, Birnbaum, Gensichen, Thomas Johannes Rosemann, Anja Laura Frei · 2011 · Praxis
86. Diabetes mellitus não controlada: inércia vs adesão à terapêutica
    USF Garcia de Orta, Maria João Gonçalves, Clara Barros Fonseca, USF Garcia de Orta, Inês Pintalhão, USF Garcia de Orta, Rodrigo Vieira Costa, USF Garcia de Orta, Manuel O. Henriques, USF Garcia de Orta et al. · 2023 · Revista Portuguesa de Clínica Geral
87. Diabetes quality of care at a university community in B eirut
    Najla A. Lakkis, Dina M. Mahmassani, Ghassan N. Hamadeh · 2015 · Journal of Evaluation in Clinical Practice
88. Quality of care for type 2 diabetes mellitus in Tripoli Medical Center: a retrospective study of 628 patients
    Hawa Juma El-Shareif · 2018 · Clinical Diabetology
89. Failure to control risk factors among patients with type 2 diabetes; experience from a Greek cohort
    Αναστάσιος Κόλλιας, Ioannis A. Bliziotis, Apostolos Xilomenos, Apostolos Tolis · 2009 · Primary care diabetes
90. Improving Blood Pressure Control in Individuals with Diabetes: A Quality Improvement Collaborative
    Margaret A. Powers, Robert M Cuddihy, Richard M. Bergenstal, Pamela Tompos, Jan Pearson, Blaine Morgan · 2011 · The Joint Commission Journal on Quality and Patient Safety
91. Characteristics and efficacy of physical activity interventions to improve cardiometabolic and psychosocial outcomes in people living with HIV in sub-Saharan Africa: a protocol for a systematic review
    S.Z. Mabweazara, Jennifer Manne‐Goehler, Mark Hamer, Jacqueline Cellini, Mark Jacob Siedner · 2023 · Systematic Reviews
92. The achievement of target cholesterol level differs between coronary heart disease and diabetic patients
    Avishay Elis, Gabriel Chodick, Anthony David Heymann, Ehud S. Kokia, Shira Flash, Michael Lishner, Varda Shalev · 2011 · European Journal of Internal Medicine
93. Inercia terapéutica en el control glucémico de la diabetes mellitus tipo 2: inconvenientes y ventajas
    Manel Mata‐Cases · 2012 · Hipertensión y Riesgo Vascular
94. The role of electronic medical records in the identification of suboptimal prescribing for hypertension management: an opportunity in unchanged therapy
    Depak K Patel, Jim Warren, John Kennelly, Kuinileti Chang Wai · 2013
95. Leveraging Healthcare System Data to Identify High-Risk Dyslipidemia Patients
    Nayrana Griffith, Grace E. Bigham, Aparna P. Sajja, Ty J. Gluckman · 2022 · Current Cardiology Reports
96. Low-Intensity Intervention Supports Diabetes Registry Implementation: A Cluster-Randomized Trial in the Ambulatory Care Outcomes Research Network (ACORN)
    Roy Sabo, Rebecca Etz, Martha M. Gonzalez, Nicole J. Johnson, Jonathan P. O’Neal, Sarah R. Reves, Jesse C. Crosson · 2020 · The Journal of the American Board of Family Medicine
97. Grado de control metabólico en pacientes ambulatorios con diabetes mellitus tipo 2 en Medicina Interna. Estudio BARVI
    Paula María Pesqueira Fontán, Jesús Grandes Ibáñez, Carolina Rodríguez-Gallego López, Sonia Molinos Castro, Laura González Vázquez, Julio de la Cruz Álvarez, Rubén Puerta-Louro, María del Carmen Gayol Fernández, José Antonio Díaz Peromingo · 2012 · Gaceta Médica de Bilbao
98. Proactive Cardiovascular Risk Management versus Usual Care in Patients with and without Diabetes Mellitus: CRUCIAL Trial Subanalysis
    Jae-Hyung Kim, José Luís Zamorano, Serap E. Erdine, Abel Pavía, Ayman S. Al-Khadra, Santosh Sutradhar · 2012 · Postgraduate Medicine
99. Poor outcomes in diabetes care: is medication nonadherence or lack of treatment intensification to blame?
    Alexander Turchin · 2008 · Nature Clinical Practice Endocrinology &#38 Metabolism
100. Access, Quality, and Cost
     Julie A. Schmittdiel, Marsha A. Raebel · 2016 · CRC Press eBooks